Press Releases Codexis, Inc.

Equities

CDXS

US1920051067

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
3.61 ^USD	-4.24%		-0.28%	+18.36%

May. 14	Codexis, Inc. Presents Enzymatic Synthesis Data at TIDES USA Annual Meeting and Launches RNA Ligase Screening and Optimization Services	CI
May. 02	Earnings Flash (CDXS) CODEXIS Posts Q1 Revenue $17.1M, vs. Street Est of $13.3M	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting	May. 14	AQ
Codexis: Q1 Earnings Snapshot	May. 02	AQ
Codexis : Q1 2024 Results	May. 02	PU
Codexis Reports First Quarter 2024 Financial Results	May. 02	AQ
Codexis to Report First Quarter 2024 Financial Results on May 2	Apr. 18	AQ
Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board	Apr. 11	AQ
Codexis: Q4 Earnings Snapshot	Feb. 28	AQ
Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results	Feb. 28	AQ
Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche	Feb. 26	AQ
Codexis to Participate in TD Cowen 44th Annual Health Care Conference	Feb. 26	AQ
Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board	Feb. 20	AQ
Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28	Feb. 14	AQ
Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones	Feb. 13	AQ
SeqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting	Feb. 01	AQ
Codexis : Termination of Material Agreement - Form 8-K	Dec. 27	PU
Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108	Dec. 27	AQ
"Dyadic International Inc. (NASDAQ: DYAI) Advances Biopharmaceutical Innovations and Vaccine Manufacturing Globally"	Dec. 21	AQ
Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform	Dec. 13	AQ
Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase	Dec. 13	AQ
Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics Manufacturing	Dec. 11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Codexis, Inc.

Equities

CDXS

US1920051067

Press Releases

Filters